Pomegranate and licorice juices modulate metformin pharmacokinetics in rats
- PMID: 27618606
Pomegranate and licorice juices modulate metformin pharmacokinetics in rats
Abstract
Objectives: Food or drinks may significantly alter the pharmacokinetics and pharmacodynamics of drugs which may lead to adverse events. A drug such as metformin is widely used to regulate plasma glucose level and pomegranate and licorice have been identified to help in type-2 diabetes management. However, the interactions of the latter on metformin pharmacokinetics were not studied. Therefore, we aimed here to study the impact of pomegranate and licorice on metformin pharmacokinetics in rats.
Methods: Juices were given to rats for two days and half an hour before metformin (20 mg/kg) oral administration. Blood samples, then, were collected at different time intervals, processed and analyzed using validated reliable HPLC method. Plasma profile and pharmacokinetic parameters were calculated for each group.
Results and conclusion: Pre-administration of pomegranate significantly reduced metformin maximum plasma concentration from 1410 to 1031 ng/ml. On the other hand, pre-administration of licorice significantly delayed metformin reaching its maximum plasma concentration. In conclusion, pre-administration of pomegranate may potentially reduce efficacy of metformin while licorice might delay metformin action. Thus, both juices should be cautiously administrated with metformin, the mainstay drug for type-2 diabetes mellitus management.
Similar articles
-
Study the influence of licorice and pomegranate drinks on nicotine metabolism in human urine by LC-orbitrap MS.J Pharm Biomed Anal. 2017 Jan 5;132:60-65. doi: 10.1016/j.jpba.2016.09.026. Epub 2016 Sep 28. J Pharm Biomed Anal. 2017. PMID: 27693954
-
Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats.Drug Metab Dispos. 2007 Feb;35(2):302-5. doi: 10.1124/dmd.106.011718. Epub 2006 Nov 28. Drug Metab Dispos. 2007. PMID: 17132763
-
Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.Curr Med Res Opin. 2006 Oct;22(10):1939-47. doi: 10.1185/030079906X132587. Curr Med Res Opin. 2006. PMID: 17022853 Clinical Trial.
-
Is Metformin a Perfect Drug? Updates in Pharmacokinetics and Pharmacodynamics.Curr Pharm Des. 2017;23(17):2532-2550. doi: 10.2174/1381612822666161201152941. Curr Pharm Des. 2017. PMID: 27908266 Review.
-
Analytical Methods for Metformin Estimation.Crit Rev Anal Chem. 2017 Sep 3;47(5):405-417. doi: 10.1080/10408347.2017.1304200. Epub 2017 Mar 10. Crit Rev Anal Chem. 2017. PMID: 28282223 Review.
Cited by
-
The Validation and Determination of Empagliflozin Concentration in the Presence of Grapefruit Juice Using HPLC for Pharmacokinetic Applications.Molecules. 2024 Mar 11;29(6):1236. doi: 10.3390/molecules29061236. Molecules. 2024. PMID: 38542873 Free PMC article.
-
Impact of Pomegranate Juice on the Pharmacokinetics of CYP3A4- and CYP2C9-Mediated Drugs Metabolism: A Preclinical and Clinical Review.Molecules. 2023 Feb 24;28(5):2117. doi: 10.3390/molecules28052117. Molecules. 2023. PMID: 36903363 Free PMC article. Review.
-
Pharmacokinetic Interaction of Green Rooibos Extract With Atorvastatin and Metformin in Rats.Front Pharmacol. 2019 Oct 23;10:1243. doi: 10.3389/fphar.2019.01243. eCollection 2019. Front Pharmacol. 2019. PMID: 31708777 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical